Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has submitted a supplemental application to ANVISA, the ...
Zacks Small Cap Research on MSN
QNRX: Believe conditional FDA approval of proposed brand name reflects QRX003 nearing potential commercialization
By M. Marin NASDAQ: QNRX READ THE FULL QNRX RESEARCH REPORT Among broadest development pipelines focused on rare dermatologic ...
After his recent arrest and suspension, Clemson defensive tackle Vic Burley took to social media for an apology.
Applications decided by North East Detbyshire District Council: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results